Last updated on October 2017

Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder


Brief description of study

The purpose of this study is to evaluate the efficacy of suvorexant, added to existing medications, for treatment-resistant insomnia in individuals with bipolar disorder. The investigators hypothesize that participants receiving suvorexant for one week will experience significantly greater improvement in sleep duration compared to participants receiving placebo.

Detailed Study Description

Participants will be randomized to receive double-blind suvorexant or placebo for one week, after which all participants will receive open treatment with suvorexant for three months.

Clinical Study Identifier: NCT02527564

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lauren Chang, B.S.

Stanford University
Stanford, CA United States
  Connect »